SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-132571
Filing Date
2016-11-09
Accepted
2016-11-09 08:40:11
Documents
43
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v451688_10q.htm 10-Q 258625
2 EXHIBIT 31.1 v451688_ex31-1.htm EX-31.1 9438
3 EXHIBIT 32.1 v451688_ex32-1.htm EX-32.1 4343
  Complete submission text file 0001144204-16-132571.txt   2217932

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ttnp-20160930.xml EX-101.INS 447343
5 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20160930.xsd EX-101.SCH 24327
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20160930_cal.xml EX-101.CAL 22708
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20160930_def.xml EX-101.DEF 144785
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20160930_lab.xml EX-101.LAB 189376
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20160930_pre.xml EX-101.PRE 169402
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 161982885
SIC: 2836 Biological Products, (No Diagnostic Substances)